• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有长期肠道保留性的三元菊粉水凝胶,可同时逆转 IBD 及其纤维化并发症。

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication.

机构信息

School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.

School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, China.

出版信息

Nat Commun. 2024 Sep 28;15(1):8428. doi: 10.1038/s41467-024-52722-7.

DOI:10.1038/s41467-024-52722-7
PMID:39341804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11438902/
Abstract

Excessive accumulation of reactive oxygen and nitrogen species (RONS) and dysbiosis of intestinal microbiota are pivotal symptoms for inflammatory bowel disease (IBD) and its associated complications, such as intestinal fibrosis. This research introduces a probiotic inulin hydrogel loaded with polypyrrole (PPy) nanozymes and antifibrotic drug pirfenidone (PFD) (PPy/PFD@Inulin gel) designed for the concurrent amelioration of IBD and its fibrotic complication. Upon oral administration, the inulin gel matrix could extend the gastrointestinal residence time of PPy nanozymes and PFD, facilitating the efficient reduction of pro-inflammatory cytokine levels and enhancement of the intestinal epithelial barrier repair as well as the suppression of intestinal fibrosis through sustained RONS scavenging, modulation of gut microbiota and attenuation of the TGF-β/Smad signaling pathway to inhibit fibroblast proliferation. Notably, the PPy/PFD@Inulin gel demonstrated significant prophylactic and therapeutic efficacy in acute and chronic colitis as well as intestinal fibrosis induced by dextran sodium sulfate (DSS) in mouse models. Thus, the engineered ternary PPy/PFD@Inulin gel offered a pioneered paradigm for simultaneous reversal of IBD and its associated complications, such as intestinal fibrosis, in a single therapeutic regimen.

摘要

活性氧和氮物种(RONS)的过度积累以及肠道微生物群落失调是炎症性肠病(IBD)及其相关并发症(如肠道纤维化)的关键症状。本研究介绍了一种载有聚吡咯(PPy)纳米酶和抗纤维化药物吡非尼酮(PFD)的益生菌菊粉水凝胶(PPy/PFD@Inulin gel),旨在同时改善 IBD 及其纤维化并发症。口服后,菊粉凝胶基质可以延长 PPy 纳米酶和 PFD 的胃肠道驻留时间,通过持续清除活性氧和氮物种、调节肠道微生物群落以及抑制 TGF-β/Smad 信号通路来抑制成纤维细胞增殖,从而有效降低促炎细胞因子水平、增强肠道上皮屏障修复并抑制肠道纤维化。值得注意的是,PPy/PFD@Inulin 水凝胶在 DSS 诱导的急性和慢性结肠炎以及肠道纤维化小鼠模型中表现出显著的预防和治疗效果。因此,该工程化的三元 PPy/PFD@Inulin 水凝胶为单一治疗方案同时逆转 IBD 及其相关并发症(如肠道纤维化)提供了开创性的范例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/a7e949bf6550/41467_2024_52722_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/42d91fcfe448/41467_2024_52722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/84d8a5449754/41467_2024_52722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/6e9862cc5ff3/41467_2024_52722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/236981bc7251/41467_2024_52722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/97196add5553/41467_2024_52722_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/310f6514f444/41467_2024_52722_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/1365352edf86/41467_2024_52722_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/20d0bd0d42ad/41467_2024_52722_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/db6aff55d8e2/41467_2024_52722_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/a7e949bf6550/41467_2024_52722_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/42d91fcfe448/41467_2024_52722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/84d8a5449754/41467_2024_52722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/6e9862cc5ff3/41467_2024_52722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/236981bc7251/41467_2024_52722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/97196add5553/41467_2024_52722_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/310f6514f444/41467_2024_52722_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/1365352edf86/41467_2024_52722_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/20d0bd0d42ad/41467_2024_52722_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/db6aff55d8e2/41467_2024_52722_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d56c/11438902/a7e949bf6550/41467_2024_52722_Fig10_HTML.jpg

相似文献

1
Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication.具有长期肠道保留性的三元菊粉水凝胶,可同时逆转 IBD 及其纤维化并发症。
Nat Commun. 2024 Sep 28;15(1):8428. doi: 10.1038/s41467-024-52722-7.
2
Comprehensive Management of Ulcerative Colitis and its Associated Intra-Extra Intestinal Complications with a Multifunctional Inulin Hydrogel Complex.使用多功能菊粉水凝胶复合物对溃疡性结肠炎及其相关肠内外并发症进行综合管理。
Small. 2025 Jun;21(23):e2500726. doi: 10.1002/smll.202500726. Epub 2025 Apr 22.
3
Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.在小鼠结肠炎模型中,口服吡非尼酮通过抑制成纤维细胞增殖和TGF-β信号传导来预防纤维化。
Biochem Pharmacol. 2016 Oct 1;117:57-67. doi: 10.1016/j.bcp.2016.08.002. Epub 2016 Aug 4.
4
Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.壳寡糖作为炎症性肠病的潜在治疗方法:治疗效果和可能的作用机制。
Pharmacol Res. 2012 Jul;66(1):66-79. doi: 10.1016/j.phrs.2012.03.013. Epub 2012 Mar 28.
5
Orally Administrated Inulin-Modified Nanozymes for CT-Guided IBD Theranostics.用于CT引导的炎症性肠病诊疗的口服菊粉修饰纳米酶
Int J Nanomedicine. 2025 Feb 18;20:2119-2131. doi: 10.2147/IJN.S497558. eCollection 2025.
6
Deletion of SOCS2 Reduces Post-Colitis Fibrosis via Alteration of the TGFβ Pathway.SOCS2 缺失通过改变 TGFβ 通路减少结肠炎后纤维化。
Int J Mol Sci. 2020 Apr 27;21(9):3073. doi: 10.3390/ijms21093073.
7
W-GA nanodots restore intestinal barrier functions by regulating flora disturbance and relieving excessive oxidative stress to alleviate colitis.W-GA 纳米点通过调节菌群紊乱和缓解过度氧化应激来恢复肠道屏障功能,从而缓解结肠炎。
Acta Biomater. 2024 Jul 1;182:260-274. doi: 10.1016/j.actbio.2024.05.030. Epub 2024 May 21.
8
Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases.工程益生菌重塑肠道上皮屏障并增强对炎症性肠病的细菌疗法。
Acta Biomater. 2025 May 15;198:467-481. doi: 10.1016/j.actbio.2025.04.016. Epub 2025 Apr 8.
9
Therapeutic Efficacy and Underlying Mechanisms of a Mannoglucan from Mycelium on Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease in Mice: Modulation of the Intestinal Barrier, Oxidative Stress and Gut Microbiota.来自菌丝体的甘露葡聚糖对葡聚糖硫酸钠诱导的小鼠炎症性肠病的治疗效果及潜在机制:对肠道屏障、氧化应激和肠道微生物群的调节
Int J Mol Sci. 2024 Dec 5;25(23):13100. doi: 10.3390/ijms252313100.
10
Micro Integral Membrane Protein (MIMP), a Newly Discovered Anti-Inflammatory Protein of Lactobacillus Plantarum, Enhances the Gut Barrier and Modulates Microbiota and Inflammatory Cytokines.微小整合膜蛋白(MIMP)是植物乳杆菌新发现的一种抗炎蛋白,可增强肠道屏障并调节微生物群和炎性细胞因子。
Cell Physiol Biochem. 2018;45(2):474-490. doi: 10.1159/000487027. Epub 2018 Jan 25.

引用本文的文献

1
Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease.基于发病机制指导的纳米酶在炎症性肠病治疗中的应用
Mater Today Bio. 2025 Jun 21;33:102008. doi: 10.1016/j.mtbio.2025.102008. eCollection 2025 Aug.
2
The Role of Akkermansia muciniphila in Disease Regulation.嗜黏蛋白阿克曼氏菌在疾病调节中的作用。
Probiotics Antimicrob Proteins. 2025 Jul 9. doi: 10.1007/s12602-025-10642-y.
3
Tumor vessel-adaptable adhesive and absorbable microspheres for sustainable transarterial chemoembolization therapy.

本文引用的文献

1
A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel-Based Multistage NO Delivery Microcapsules.基于纳米凝胶的多阶段 NO 递送微胶囊的气体治疗策略调节肠道菌群和治疗结肠炎。
Adv Mater. 2024 May;36(19):e2309972. doi: 10.1002/adma.202309972. Epub 2024 Feb 13.
2
HS-Releasing Versatile Montmorillonite Nanoformulation Trilogically Renovates the Gut Microenvironment for Inflammatory Bowel Disease Modulation.HS 释放多功能蒙脱石纳米制剂三重改造肠道微环境用于炎症性肠病调节。
Adv Sci (Weinh). 2024 Apr;11(14):e2308092. doi: 10.1002/advs.202308092. Epub 2024 Feb 2.
3
Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis.
用于可持续经动脉化疗栓塞治疗的肿瘤血管适应性粘附和可吸收微球
Nat Commun. 2025 Jul 7;16(1):6239. doi: 10.1038/s41467-025-61621-4.
4
ER stress genes () predicts IKK-16 as a Candidate therapeutic target for colitis-related inflammation and fibrosis suppression.内质网应激基因()预测IKK-16是抑制结肠炎相关炎症和纤维化的候选治疗靶点。
Front Immunol. 2025 Jun 18;16:1587860. doi: 10.3389/fimmu.2025.1587860. eCollection 2025.
5
The role of plant-based dietary compounds in gut microbiota modulation in inflammatory bowel disease.植物性膳食化合物在炎症性肠病中调节肠道微生物群的作用。
Front Nutr. 2025 May 30;12:1606289. doi: 10.3389/fnut.2025.1606289. eCollection 2025.
6
Multi-Functional Applications of Hydrogel Delivery Systems in Inflammatory Bowel Disease: Drug Delivery, Anti-Inflammation, and Intestinal Repair.水凝胶递送系统在炎症性肠病中的多功能应用:药物递送、抗炎和肠道修复
Polymers (Basel). 2025 May 22;17(11):1430. doi: 10.3390/polym17111430.
7
Inflammation Targeting-Triggered Healing Hydrogel for In Situ Reconstruction of Colonic Mucosa.用于结肠黏膜原位重建的炎症靶向触发愈合水凝胶
Adv Sci (Weinh). 2025 Mar;12(10):e2411010. doi: 10.1002/advs.202411010. Epub 2025 Jan 15.
8
Copper-luteolin nanocomplexes for Mediating multifaceted regulation of oxidative stress, intestinal barrier, and gut microbiota in inflammatory bowel disease.用于介导炎症性肠病中氧化应激、肠道屏障和肠道微生物群多方面调节的铜-木犀草素纳米复合物
Bioact Mater. 2024 Dec 11;46:118-133. doi: 10.1016/j.bioactmat.2024.12.004. eCollection 2025 Apr.
脱硫弧菌与新型肠道上皮免疫受体 LRRC19 相互作用并加剧结肠炎。
Microbiome. 2024 Jan 3;12(1):4. doi: 10.1186/s40168-023-01722-8.
4
An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease.一种包埋奥沙拉嗪纳米针的菊粉水凝胶重塑炎症性肠病中的肠道稳态。
Bioact Mater. 2023 Nov 8;33:71-84. doi: 10.1016/j.bioactmat.2023.10.028. eCollection 2024 Mar.
5
Nanocrystalline Cellulose Modulates Dysregulated Intestinal Barriers in Ulcerative Colitis.纳米晶纤维素调节溃疡性结肠炎中失调的肠道屏障。
ACS Nano. 2023 Oct 10;17(19):18965-18978. doi: 10.1021/acsnano.3c04569. Epub 2023 Sep 25.
6
Rational Design of Orally Administered Cascade Nanozyme for Inflammatory Bowel Disease Therapy.口服级联纳米酶的合理设计用于炎症性肠病治疗。
Adv Mater. 2023 Nov;35(44):e2304967. doi: 10.1002/adma.202304967. Epub 2023 Sep 21.
7
Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid.副拟杆菌通过其代谢产物十五烷酸利用膳食菊粉来抑制 NASH。
Nat Microbiol. 2023 Aug;8(8):1534-1548. doi: 10.1038/s41564-023-01418-7. Epub 2023 Jun 29.
8
Design principles of food gels.食品凝胶的设计原理。
Nat Food. 2020 Feb;1(2):106-118. doi: 10.1038/s43016-019-0009-x. Epub 2020 Feb 18.
9
Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis.携载人工酶的长双歧杆菌益生菌缓解肠道炎症和微生态失调。
Nat Nanotechnol. 2023 Jun;18(6):617-627. doi: 10.1038/s41565-023-01346-x. Epub 2023 Mar 27.
10
Oral Metal-Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD).口腔无金属黑色素纳米酶用于自然且持久的靶向治疗炎症性肠病 (IBD)。
Small. 2023 May;19(19):e2207350. doi: 10.1002/smll.202207350. Epub 2023 Feb 9.